Sushil Finance's report on Cadila Healthcare "Cadila Healthcare reported disappointing set of numbers in Q2FY14 on the domestic formulations & margins front, however export formulations reported strong growth. Net sales & EBITDA up 13 percent ... Moneycontrol.com, 3 weeks ago
/PRNewswire/ -- Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues Do you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue ...Individual.com, 1 week ago
OncoMed Pharmaceuticals, Inc. (OMED) is an early developmental-stage biotechnology company focused on discovering and developing first-in-class monoclonal antibody ("MAB") therapeutics targeting cancer stem cells ("CSCs"). Based in Redwood City, ...Seeking Alpha, 1 month ago
This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the ...Sys-Con Media, 1 month ago
on your WebpageAdd Widget >Get your members hooked!